Phase 4 Chronic Kidney Diseases trials recruiting now
All Chronic Kidney Diseases trials, every phase
11
Phase 4 recruiting
Other phases for Chronic Kidney Diseases
Phase 4 Chronic Kidney Diseases trials
- A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease (CKD).(Real World Evidence Study)
- A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
- Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation
- Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2
- Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
- Oral Iron in Children With Chronic Kidney Disease
- Potassium Correction for RAAS Optimization in Chronic Kidney Disease
- Role of Coenzyme Q10 in Chronic Kidney Disease
- Role of Vitamin K2 in Chronic Kidney Disease
- Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
Common questions
What does Phase 4 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.